Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PPARG | P37231 | 3/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL195032 | 0.81 | L3MBTL1 (0.50) | L3MBTL1MAOBAOC3TSHRMAPK1 | |
| SCHEMBL30213947 | 0.81 | L3MBTL1 (0.50) | L3MBTL1MAOBAOC3TSHRMAPK1 | |
| SCHEMBL9797305 | 0.78 | MAOB (0.43) | L3MBTL1MAOBAOC3TSHRMAPK1 | |
| SCHEMBL29782607 | 0.78 | L3MBTL1 (0.58) | L3MBTL1MAOBTSHRMAPK1ALDH1A1 | |
| SCHEMBL167016 | 0.78 | L3MBTL1 (0.58) | L3MBTL1MAOBTSHRMAPK1ALDH1A1 | |
| SCHEMBL9798371 | 0.77 | LTA4H (0.54) | L3MBTL1MAOBAOC3TSHRMAPK1 | |
| SCHEMBL17117545 | 0.77 | L3MBTL1 (0.43) | L3MBTL1MAOBAOC3TSHRMAPK1 | |
| SCHEMBL27295380 | 0.76 | MAPT (0.57) | L3MBTL1TSHRMAPK1ALDH1A1POLB | |
| SCHEMBL535428 | 0.75 | CA1 (0.44) | MAOBAOC3TSHRALDH1A1 | |
| SCHEMBL2737127 | 0.74 | L3MBTL1 (0.47) | L3MBTL1MAOBAOC3TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060189641-A1 | Novel 6-phenlyphenanthridines | NYCOMED GMBH (DE) | 2006-08-24 | — | — | US | claimed |
| EP-1658271-A1 | NOVEL 6-PHENYLPHENANTHRIDINES | ALTANA Pharma AG (DE) | 2006-05-24 | — | — | EP | claimed |
| WO-2005012253-A1 | NOVEL 6-PHENYLPHENANTHRIDINES | ALTANA PHARMA AG (DE) | 2005-02-10 | — | — | WO | claimed |
| US-5120849-A | Reacting cyclic imidoether with aminoalcohol | BASF AKTIENGESELLSCHAFT (DE) | 1992-06-09 | — | — | US | claimed |
| US-8247431-B2 | Heterocyclic hydrazide compound and pesticidal use of the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-21 | — | — | US | disclosed |
| EP-2144898-B1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL CO (JP) | 2012-02-08 | — | — | EP | disclosed |
| US-20100137362-A1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20060189641-A1 | Novel 6-phenlyphenanthridines | NYCOMED GMBH (DE) | 2006-08-24 | — | — | US | disclosed |
| EP-1658271-A1 | NOVEL 6-PHENYLPHENANTHRIDINES | ALTANA Pharma AG (DE) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005012253-A1 | NOVEL 6-PHENYLPHENANTHRIDINES | ALTANA PHARMA AG (DE) | 2005-02-10 | — | — | WO | disclosed |
| US-5120849-A | Reacting cyclic imidoether with aminoalcohol | BASF AKTIENGESELLSCHAFT (DE) | 1992-06-09 | — | — | US | disclosed |
| EP-0244786-B1 | PROCESS FOR PREPARING 0-SUBSTITUTED HYDROXYLAMINES | BASF Aktiengesellschaft (DE) | 1991-03-06 | — | — | EP | disclosed |
| EP-0244786-A1 | Process for preparing 0-substituted hydroxylamines | BASF Aktiengesellschaft (DE) | 1987-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060189641-A1 | Novel 6-phenlyphenanthridines | PDE4A, PDE4B, PDE4C | L3MBTL1 3259/4885MAOB 516/4885AOC3 3250/4885 |
| US-20100137362-A1 | HETEROCYCLIC HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME | ACHE, CAT, DNPH1 | L3MBTL1 3467/4885MAOB 393/4885AOC3 625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.